Hjem › Mavekreft › Missouri › St. Louis
Kliniske studier for Mavekreft i St. Louis, MO
18 studier for Mavekreft søker deltakere på steder i og rundt St. Louis (innen ca. 30 miles). Åpne et studie for å se hvem som kan delta og hvordan du kontakter studieteamet.
Offisiell studietekst (engelsk)
Rekrutterer til et studie her? Få det fremtredende øverst på siden – $99 i 30 dager →
The Vanguard Study: Testing a New Way to Screen for Cancer
RekruttererFrivillige helsepersonell ønskes velkommen
- Washington University School of Medicine, St Louis
Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays
RekruttererFrivillige helsepersonell ønskes velkommen
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- og 4 flere
Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection
RekruttererObservasjonsstudieFrivillige helsepersonell ønskes velkommen
- Mercy Infusion Center - Chippewa, St Louis
- Mercy Hospital South, St Louis
- Missouri Baptist Medical Center, St Louis
- og 4 flere
A Study of HER3-DXd in Subjects With Locally Advanced or Metastatic Solid Tumors
RekruttererFase 2
- Washington University, School of Medicine, St Louis
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
RekruttererFase 1
- Washington University, St Louis
A Study of LY4337713 in Participants With FAP-Positive Solid Tumors
RekruttererFase 1
- Washington University School of Medicine in St. Louis, St Louis
Study of AU-007, A Monoclonal Antibody That Binds to IL-2 and Inhibits IL-2Rα Binding, in Patients With Unresectable Locally Advanced or Metastatic Cancer
RekruttererFase 1/2
- Washington University, St Louis
Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2
RekruttererFase 3
- Research Site, St Louis
A Phase 1/1b Study of IAM1363 in HER2 Cancers
RekruttererFase 1
- Washington University School of Medicine, St Louis
Ovarian-Sparing Adaptive Radiotherapy in Young Adult Women
RekruttererObservasjonsstudie
- Washington University School of Medicine, St Louis
A Study to Investigate Safety of AZD6750 in Adult Participants With Select Advanced or Metastatic Solid Tumors
RekruttererFase 1/2
- Research Site, St Louis
IDOV-Immune for Advanced Solid Tumors
RekruttererFase 1
- Washington University School of Medicine, St Louis
A Study of Bispecific Antibody MCLA-158 in Patients With Advanced Solid Tumors
RekruttererFase 1/2
- Washington University School of Medicine at St Louis, St Louis
Study of Orally Administered MOMA-341 in Participants With Advanced or Metastatic Solid Tumors
RekruttererFase 1
- Investigative Site #110, St Louis
Lead-212 PSV359 Therapy for Patients With Solid Tumors
RekruttererFase 1/2
- Saint Louis University, St Louis
CA-4948 in Combination With FOLFOX/PD-1 Inhibitor +/- Trastuzumab for Untreated Unresectable Gastric and Esophageal Cancer
RekruttererFase 1
- Washington University School of Medicine, St Louis
A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer
RekruttererFase 3
- Washington University School of Medicine St. Louis, St Louis
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
RekruttererObservasjonsstudie
- Massive Bio SYNERGY-AI site, St Louis
Mavekreft-studier i andre byer
- Houston, TX42 studier
- Boston, MA32 studier
- New York City, NY31 studier
- Nashville, TN28 studier
- Baldwin Park, CA22 studier
- Los Angeles, CA22 studier
- Arlington, VA20 studier
- San Antonio, TX19 studier
- Dallas, TX19 studier
- Grand Rapids, MI18 studier
- Washington, DC16 studier
- Detroit, MI16 studier
Andre studier i St. Louis
- Ikke-småcellet lungekreft73 studier
- Brystkreft65 studier
- Metastatisk kreft54 studier
- Kolorektal kreft51 studier
- Kreft (alle typer)47 studier
- Prostatakreft46 studier
- Lungekreft39 studier
- Eggstokkreft38 studier
- Pankreaskreft33 studier
- Endometriekreft29 studier
- Plateepitelcancer i hode og hals28 studier
- Hjertesvikt26 studier
Fra ClinicalTrials.gov, data hentet 7. okt. 2026. Hver studie setter sine egne kvalifikasjonskrav; studieteamet avgjør hvem som kan delta.